A successful example of this approach was the identification of methyl-CpG binding protein 2 (MECP2; a binder of methylated DNA) mutations in Rett syndrome, a well-studied neurodevelopmental disorder (NDD). The gene discussed is MECP2; the disease is atypical Rett syndrome.